HEYL, SLC2A3, and FBN1 were found to mediate tumor progression and chemoresistance mainly by facilitating angiogenesis and EMT [35–37], while CERCAM, ANXA1, and SPOCD1 promoted tumor progression through the PI3K/AKT and EGFR signaling pathways. Here, EGFR is linked to neoplasm.